Literature DB >> 18049723

To treat or not to treat...Is it still the question?

Andres M Kanner.   

Abstract

Year:  2007        PMID： 18049723      PMCID： PMC2096727          DOI： 10.1111/j.1535-7511.2007.00210.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy.

Authors:  Maurizio A Leone; Alessandra Solari; Ettore Beghi
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

2.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

3.  Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

Authors:  M Musicco; E Beghi; A Solari; F Viani
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

4.  Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group)

Authors: 
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

5.  Factors prognostic of unprovoked seizures after febrile convulsions.

Authors:  J F Annegers; W A Hauser; S B Shirts; L T Kurland
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

6.  Prognostic index for recurrence of seizures after remission of epilepsy. Medical Research Council Antiepileptic Drug Withdrawal Study Group.

Authors: 
Journal:  BMJ       Date:  1993-05-22

7.  Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood.

Authors:  Peter Camfield; Carol Camfield; Stephanie Smith; Joe Dooley; Edythe Smith
Journal:  Epilepsia       Date:  2002-06       Impact factor: 5.864

8.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

9.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.